Progesterone Treatment for Sleep Quality Improvement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for perturbed sleep patterns, such as mid-sleep period awakenings, are not effective in improving sleep quality, as commercially available hypnotics like benzodiazepines do not consistently increase slow-wave sleep (SWS) or REM sleep and often worsen sleep patterns.
Innovation Solution
Administering a therapeutically effective amount of progesterone, either alone or in combination with progesterone analogs, to regulate sleep architecture by increasing SWS and REM sleep, and reducing wake time, which can be done through daily oral administration, particularly before retiring, and potentially with additional doses during the sleep period.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional hypnotics like benzodiazepines are administered to improve sleep efficiency, then sleep efficiency is improved, but slow-wave sleep (SWS) and REM sleep are not consistently increased and sleep patterns are worsened
Solution Approach 1:
The patent changes the chemical substance parameter from conventional hypnotics (benzodiazepines, Z-compounds) to progesterone, which has different pharmacological properties. Progesterone acts on GABA-A receptors but produces distinct effects on sleep architecture, specifically increasing SWS and REM sleep while improving sleep efficiency, thereby resolving the contradiction between sleep efficiency improvement and sleep pattern quality preservation
2Loss of time
If hypnotics are used to treat patients who have trouble falling asleep, then sleep onset is improved, but mid-sleep period awakenings are not effectively treated and sleep patterns are modified adversely
Solution Approach 1:
The patent changes the active substance from conventional hypnotics to progesterone, which has a unique effect on sleep architecture. Progesterone not only helps with sleep onset but also maintains sleep continuity and improves mid-sleep period awakenings by increasing SWS and REM sleep, thereby treating both sleep onset and sleep maintenance issues without adverse pattern modifications
3Reliability
If progesterone is administered to increase slow-wave sleep (SWS) and REM sleep, then sleep architecture is improved, but the dosage and administration timing must be precisely controlled
Solution Approach 1:
The patent establishes predetermined dosing regimens and administration timing (e.g., evening administration before bedtime) based on progesterone's pharmacokinetics and circadian rhythm considerations. This preliminary planning of dosage and timing simplifies the administration process while ensuring optimal sleep architecture improvement, reducing the complexity of dosage control
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Progesterone improves sleep quality by decreasing wake time, increasing SWS and REM sleep, enhancing sleep maintenance, and normalizing the distribution of sleep stages, effectively addressing the limitations of conventional hypnotics in treating mid-sleep awakenings and environment-related sleep disturbances.
Implementation Method 1
Progesterone and its metabolites interact with the GABA system, in particular with the GABA-A receptor complex
Data Source
AI summary
Described herein are therapeutic methods using progesterone and progesterone analogs to improve sleep quality. The methods may be particularly useful to treat subject with perturbed sleep patterns, such as subjects who suffer from mid-sleep period awakenings.